New drugs in the treatment of chronic hepatitis C

Objectives: To analyze the efficacy and safety of the new direct antiviralagents (DAA) that will become the new therapeutic arsenal for thetreatment of hepatitis C. Methods:We carried out a research in the electronic database with thefollowing criteria: phase II and III clinical trials (CT) publish...

Full description

Bibliographic Details
Main Authors: R. Jimenez Galan, Á. Albacete Ramirez, P. Monje Agudo, Y. Borrego Izquierdo, R. Morillo Verdugo
Format: Article
Language:English
Published: Grupo Aula Médica 2014-04-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/7314.pdf